The guidelines for the management of CV disease in T2DM patients maintain the same recommendation as in the general population for measuring BNP or NT-proBNP for diagnosis or prognosis assessments in the management of both HFrEF and HFpEF. The gene discussed is NPPB; the disease is type 2 diabetes mellitus.